Chi Sheng Pharma & Biotech Co (ROCO:4111) Cyclically Adjusted PB Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4111 Chi Sheng Pharma & Biotech Co Ltd ROCO:4111
85 GF Score
Price NT$28.80
GF Value NT$33.25
Valuation Modestly Undervalued
View Full Analysis

What is Chi Sheng Pharma & Biotech Co Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Chi Sheng Pharma & Biotech Co  (ROCO:4111) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Chi Sheng Pharma & Biotech Co Cyclically Adjusted PB Ratio Related Terms


Chi Sheng Pharma & Biotech Co Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Chi Sheng Pharma & Biotech Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chi Sheng Pharma & Biotech Co Cyclically Adjusted PB Ratio Chart

Chi Sheng Pharma & Biotech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.15 1.25 1.20 1.22 1.32

Chi Sheng Pharma & Biotech Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.38 1.37 1.33 1.29 1.32

ROCO:4111 vs ISRG, BDX, RMD: Cyclically Adjusted PB Ratio Comparison

For the Medical Instruments & Supplies subindustry, Chi Sheng Pharma & Biotech Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chi Sheng Pharma & Biotech Co Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Chi Sheng Pharma & Biotech Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Chi Sheng Pharma & Biotech Co's Cyclically Adjusted PB Ratio falls into.


ROCO:4111
85GF Score
Chi Sheng Pharma & Biotech Co Ltd ROCO:4111
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chi Sheng Pharma & Biotech Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Chi Sheng Pharma & Biotech Co's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Chi Sheng Pharma & Biotech Co's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=23.421/333.9520*333.9520
=23.421

Current CPI (Jun. 2026) = 333.9520.

Chi Sheng Pharma & Biotech Co Quarterly Data

Book Value per Share CPI Adj_Book
201609 16.700 241.428 23.100
201612 17.046 241.432 23.578
201703 17.231 243.801 23.603
201706 16.872 244.955 23.002
201709 17.334 246.819 23.453
201712 17.608 246.524 23.853
201803 17.850 249.554 23.887
201806 17.207 251.989 22.804
201809 17.299 252.439 22.885
201812 17.468 251.233 23.219
201903 17.818 254.202 23.408
201906 17.547 256.143 22.877
201909 17.643 256.759 22.947
201912 17.913 256.974 23.279
202003 18.283 258.115 23.655
202006 17.536 257.797 22.716
202009 17.739 260.280 22.760
202012 17.980 260.474 23.052
202103 18.162 264.877 22.898
202106 18.390 271.696 22.604
202109 17.854 274.310 21.736
202112 18.397 278.802 22.036
202203 18.949 287.504 22.010
202206 18.386 296.311 20.722
202209 19.253 296.808 21.662
202212 20.426 296.797 22.983
202303 20.739 301.836 22.946
202306 19.940 305.109 21.825
202309 20.277 307.789 22.001
202312 20.375 306.746 22.182
202403 20.761 312.332 22.198
202406 20.152 314.175 21.421
202409 20.490 315.301 21.702
202412 21.302 315.605 22.540
202503 21.950 319.799 22.921
202506 21.578 322.561 22.340
202509 22.332 324.800 22.961
202512 23.077 324.054 23.782
202603 23.977 330.213 24.248
202606 23.421 333.952 23.421

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Chi Sheng Pharma & Biotech Co (ROCO:4111) Overvalued in 2026?

Based on GuruFocus' analysis, Chi Sheng Pharma & Biotech Co stock appears to be undervalued. The current stock price of NT$28.80 is trading 13.4% below its estimated GF Value™ of NT$33.25. GuruFocus considers Chi Sheng Pharma & Biotech Co to be Modestly Undervalued.

Key valuation signals for ROCO:4111:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: NT$33.25 vs. price of NT$28.80 (13.4% below fair value)
  • GF Score™: 85/100

No single metric tells the full story. See the ROCO:4111 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Chi Sheng Pharma & Biotech Co Business Description

Address No. 3, Shijian Road, Hsin Chu Industrial Park, Hsinchu County, Hukou, TWN, 30316
Chi Sheng Pharma & Biotech Co Ltd manufactures and distributes medical medicines and equipment in Taiwan. It offers injections, including hemodialysis solutions, amino acid injections, vitamin injections, and externally applied medicines.
85GF Score

Get the complete analysis for ROCO:4111

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$28.80
Price
NT$33.25
GF Value